{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:02:17Z","timestamp":1787061737452,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,2,24]],"date-time":"2010-02-24T00:00:00Z","timestamp":1266969600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1007\/s00105-009-1858-2","type":"journal-article","created":{"date-parts":[[2010,2,22]],"date-time":"2010-02-22T08:57:33Z","timestamp":1266829053000},"page":"195-206","source":"Crossref","is-referenced-by-count":25,"title":["Prim\u00e4r- und Sekund\u00e4rprophylaxe von Hauttumoren nach Organtransplantation","Primary and secondary prevention of skin cancer in organ transplant recipients"],"prefix":"10.1007","volume":"61","author":[{"given":"A.S.","family":"Lonsdorf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.R.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Stockfleth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Sch\u00e4kel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,2,24]]},"reference":[{"key":"1858_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mjd.2002.125579","volume":"47","author":"Berg","year":"2002","unstructured":"Berg D, Otley CC (2002) Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 47:1\u201317; quiz 18\u201320","journal-title":"J Am Acad Dermatol"},{"key":"1858_CR2","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1038\/sj.jid.5700776","volume":"127","author":"Bouwes","year":"2007","unstructured":"Bouwes Bavinck JN, Euvrard S, Naldi L et al (2007) Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: a case-control study in The Netherlands, United Kingdom, Germany, France, and Italy. J Invest Dermatol 127:1647\u20131656","journal-title":"J Invest Dermatol"},{"key":"1858_CR3","first-page":"985","volume":"141","author":"Brown","year":"2005","unstructured":"Brown Vl, Atkins Cl, Ghali L et al (2005) Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial. Arch Dermatol 141:985\u2013993","journal-title":"Arch Dermatol"},{"key":"1858_CR4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1749-6632.2001.tb02731.x","volume":"952","author":"Dannenberg","year":"2001","unstructured":"Dannenberg AJ, Altorki NK, Boyle JO et al (2001) Inhibition of cyclooxygenase-2: an approach to preventing cancer of the upper aerodigestive tract. Ann N Y Acad Sci 952:109\u2013115","journal-title":"Ann N Y Acad Sci"},{"key":"1858_CR5","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(97)08496-1","volume":"351","author":"Dantal","year":"1998","unstructured":"Dantal J, Hourmant M, Cantarovich D et al (1998) Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet 351:623\u2013628","journal-title":"Lancet"},{"key":"1858_CR6","first-page":"656","volume":"30","author":"De","year":"2004","unstructured":"De Graaf YG, Euvrard S, Bouwes Bavinck JN (2004) Systemic and topical retinoids in the management of skin cancer in organ transplant recipients. Dermatol Surg 30:656\u2013661","journal-title":"Dermatol Surg"},{"key":"1858_CR7","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/sj.jid.5700098","volume":"126","author":"De","year":"2006","unstructured":"De Graaf YG, Kennedy C, Wolterbeek R et al (2006) Photodynamic therapy does not prevent cutaneous squamous-cell carcinoma in organ-transplant recipients: results of a randomized-controlled trial. J Invest Dermatol 126:569\u2013574","journal-title":"J Invest Dermatol"},{"key":"1858_CR8","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1067\/S0190-9622(03)01831-0","volume":"49","author":"De","year":"2003","unstructured":"De Sevaux RG, Smit JV, De Jong EM et al (2003) Acitretin treatment of premalignant and malignant skin disorders in renal transplant recipients: clinical effects of a randomized trial comparing two doses of acitretin. J Am Acad Dermatol 49:407\u2013412","journal-title":"J Am Acad Dermatol"},{"key":"1858_CR9","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/S0190-9622(98)70451-7","volume":"39","author":"Digiovanna","year":"1998","unstructured":"Digiovanna JJ (1998) Retinoid chemoprevention in the high-risk patient. J Am Acad Dermatol 39:S82\u2013S85","journal-title":"J Am Acad Dermatol"},{"key":"1858_CR10","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2133.2004.06054.x","volume":"151","author":"Dragieva","year":"2004","unstructured":"Dragieva G, Prinz BM, Hafner J et al (2004) A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients. Br J Dermatol 151:196\u2013200","journal-title":"Br J Dermatol"},{"key":"1858_CR11","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMra022137","volume":"348","author":"Euvrard","year":"2003","unstructured":"Euvrard S, Kanitakis J, Claudy A (2003) Skin cancers after organ transplantation. N Engl J Med 348:1681\u20131691","journal-title":"N Engl J Med"},{"key":"1858_CR12","first-page":"628","volume":"30","author":"Euvrard","year":"2004","unstructured":"Euvrard S, Ulrich C, Lefrancois N (2004) Immunosuppressants and skin cancer in transplant patients: focus on rapamycin. Dermatol Surg 30:628\u2013633","journal-title":"Dermatol Surg"},{"key":"1858_CR13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0140-6736(92)92459-S","volume":"340","author":"Euvrard","year":"1992","unstructured":"Euvrard S, Verschoore M, Touraine Jl et al (1992) Topical retinoids for warts and keratoses in transplant recipients. Lancet 340:48\u201349","journal-title":"Lancet"},{"key":"1858_CR14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.neo.7900127","volume":"3","author":"Gallo","year":"2001","unstructured":"Gallo O, Franchi A, Magnelli L et al (2001) Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis. Neoplasia 3:53\u201361","journal-title":"Neoplasia"},{"key":"1858_CR15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1440-0960.2002.00613.x","volume":"43","author":"George","year":"2002","unstructured":"George R, Weightman W, Russ GR et al (2002) Acitretin for chemoprevention of non-melanoma skin cancers in renal transplant recipients. Australas J Dermatol 43:269\u2013273","journal-title":"Australas J Dermatol"},{"key":"1858_CR16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm0202-128","volume":"8","author":"Guba","year":"2002","unstructured":"Guba M, Von Breitenbuch P, Steinbauer M et al (2002) Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 8:128\u2013135","journal-title":"Nat Med"},{"key":"1858_CR17","first-page":"295","volume":"3","author":"Huang","year":"2002","unstructured":"Huang S, Houghton PJ (2002) Inhibitors of mammalian target of rapamycin as novel antitumor agents: from bench to clinic. Curr Opin Investig Drugs 3:295\u2013304","journal-title":"Curr Opin Investig Drugs"},{"key":"1858_CR18","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1365-2133.2006.07454.x","volume":"155","author":"Ismail","year":"2006","unstructured":"Ismail F, Mitchell L, Casabonne D et al (2006) Specialist dermatology clinics for organ transplant recipients significantly improve compliance with photoprotection and levels of skin cancer awareness. Br J Dermatol 155:916\u2013925","journal-title":"Br J Dermatol"},{"key":"1858_CR19","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1600-6143.2004.00450.x","volume":"4","author":"Kasiske","year":"2004","unstructured":"Kasiske Bl, Snyder JJ, Gilbertson DT et al (2004) Cancer after kidney transplantation in the United States. Am J Transplant 4:905\u2013913","journal-title":"Am J Transplant"},{"key":"1858_CR20","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1046\/j.1365-2133.1999.02765.x","volume":"140","author":"Mckenna","year":"1999","unstructured":"Mckenna DB, Murphy GM (1999) Skin cancer chemoprophylaxis in renal transplant recipients: 5 years of experience using low-dose acitretin. Br J Dermatol 140:656\u2013660","journal-title":"Br J Dermatol"},{"key":"1858_CR21","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/archderm.141.8.978","volume":"141","author":"Moloney","year":"2005","unstructured":"Moloney FJ, Almarzouqi E, O\u2019kelly P et al (2005) Sunscreen use before and after transplantation and assessment of risk factors associated with skin cancer development in renal transplant recipients. Arch Dermatol 141:978\u2013982","journal-title":"Arch Dermatol"},{"key":"1858_CR22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1529-8019.2005.05006.x","volume":"18","author":"Neuhaus","year":"2005","unstructured":"Neuhaus IM, Tope WD (2005) Practical retinoid chemoprophylaxis in solid organ transplant recipients. Dermatol Ther 18:28\u201333","journal-title":"Dermatol Ther"},{"key":"1858_CR23","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1365-2133.2004.06214.x","volume":"151","author":"Nijsten","year":"2004","unstructured":"Nijsten T, Colpaert CG, Vermeulen PB et al (2004) Cyclooxygenase-2 expression and angiogenesis in squamous cell carcinoma of the skin and its precursors: a paired immunohistochemical study of 35 cases. Br J Dermatol 151:837\u2013845","journal-title":"Br J Dermatol"},{"key":"1858_CR24","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.1114233","volume":"309","author":"O","year":"2005","unstructured":"O\u2019Donovan P, Perrett CM, Zhang X et al (2005) Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 309:1871\u20131874","journal-title":"Science"},{"key":"1858_CR25","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2133.2005.07087.x","volume":"154","author":"Otley","year":"2006","unstructured":"Otley CC, Berg D, Ulrich C et al (2006) Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey. Br J Dermatol 154:395\u2013400","journal-title":"Br J Dermatol"},{"key":"1858_CR26","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jaad.2005.07.061","volume":"53","author":"Otley","year":"2005","unstructured":"Otley CC, Cherikh WS, Salasche SJ et al (2005) Skin cancer in organ transplant recipients: effect of pretransplant end-organ disease. J Am Acad Dermatol 53:783\u2013790","journal-title":"J Am Acad Dermatol"},{"key":"1858_CR27","first-page":"459","volume":"137","author":"Otley","year":"2001","unstructured":"Otley CC, Coldiron BM, Stasko T et al (2001) Decreased skin cancer after cessation of therapy with transplant-associated immunosuppressants. Arch Dermatol 137:459\u2013463","journal-title":"Arch Dermatol"},{"key":"1858_CR28","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1111\/j.1600-6143.2005.01036.x","volume":"5","author":"Otley","year":"2005","unstructured":"Otley CC, Hirose R, Salasche SJ (2005) Skin cancer as a contraindication to organ transplantation. Am J Transplant 5:2079\u20132084","journal-title":"Am J Transplant"},{"key":"1858_CR29","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/00007890-199304000-00011","volume":"55","author":"Penn","year":"1993","unstructured":"Penn I (1993) The effect of immunosuppression on pre-existing cancers. Transplantation 55:742\u2013747","journal-title":"Transplantation"},{"key":"1858_CR30","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-2133.2006.07616.x","volume":"156","author":"Perrett","year":"2007","unstructured":"Perrett CM, Mcgregor JM, Warwick J et al (2007) Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy. Br J Dermatol 156:320\u2013328","journal-title":"Br J Dermatol"},{"key":"1858_CR31","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1001\/archderm.140.8.1015","volume":"140","author":"Reichrath","year":"2004","unstructured":"Reichrath J (2004) UV protection and vitamin D deficiency in transplant recipients. Arch Dermatol 140:1015\u20131016","journal-title":"Arch Dermatol"},{"key":"1858_CR32","first-page":"682","volume":"10","author":"Sachse","year":"2007","unstructured":"Sachse MM, Bahmer JA, Bahmer FA (2007) Organtransplantierte sind besonders hautkrebsgefaehrdet. Dtsch Dermatologe 10:682\u2013684","journal-title":"Dtsch Dermatologe"},{"key":"1858_CR33","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1046\/j.1365-2133.2002.49297.x","volume":"147","author":"Smit","year":"2002","unstructured":"Smit JV, Cox S, Blokx WA et al (2002) Actinic keratoses in renal transplant recipients do not improve with calcipotriol cream and all-trans retinoic acid cream as monotherapies or in combination during a 6-week treatment period. Br J Dermatol 147:816\u2013818","journal-title":"Br J Dermatol"},{"key":"1858_CR34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0190-9622(03)01837-1","volume":"50","author":"Smit","year":"2004","unstructured":"Smit JV, De Sevaux RG, Blokx WA et al (2004) Acitretin treatment in (pre)malignant skin disorders of renal transplant recipients: histologic and immunohistochemical effects. J Am Acad Dermatol 50:189\u2013196","journal-title":"J Am Acad Dermatol"},{"key":"1858_CR35","first-page":"561","volume":"27","author":"Smith","year":"2001","unstructured":"Smith KJ, Germain M, Skelton H (2001) Squamous cell carcinoma in situ (Bowen\u2019s disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluorouracil therapy. Dermatol Surg 27:561\u2013564","journal-title":"Dermatol Surg"},{"key":"1858_CR36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2133.2007.08269.x","volume":"157","author":"Ulrich","year":"2007","unstructured":"Ulrich C, Bichel J, Euvrard S et al (2007) Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients. Br J Dermatol 157(Suppl 2):25\u201331","journal-title":"Br J Dermatol"},{"key":"1858_CR37","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2133.2007.07864.x","volume":"156","author":"Ulrich","year":"2007","unstructured":"Ulrich C, Hackethal M, Ulrich M et al (2007) Treatment of multiple actinic keratoses with topical diclofenac 3% gel in organ transplant recipients: a series of six cases. Br J Dermatol 156(Suppl 3):40\u201342","journal-title":"Br J Dermatol"},{"key":"1858_CR38","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-2133.2009.09453.x","volume":"161","author":"Ulrich","year":"2009","unstructured":"Ulrich C, Jurgensen JS, Degen A et al (2009) Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study. Br J Dermatol 161(Suppl 3):78\u201384","journal-title":"Br J Dermatol"},{"key":"1858_CR39","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1111\/j.1600-6143.2008.02386.x","volume":"8","author":"Ulrich","year":"2008","unstructured":"Ulrich C, Kanitakis J, Stockfleth E et al (2008) Skin cancer in organ transplant recipients \u2013 where do we stand today? Am J Transplant 8:2192\u20132198","journal-title":"Am J Transplant"},{"key":"1858_CR40","first-page":"622","volume":"30","author":"Ulrich","year":"2004","unstructured":"Ulrich C, Schmook T, Sachse MM et al (2004) Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients. Dermatol Surg 30:622\u2013627","journal-title":"Dermatol Surg"},{"key":"1858_CR41","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/(SICI)1097-0142(19990415)85:8<1758::AID-CNCR16>3.0.CO;2-F","volume":"85","author":"Veness","year":"1999","unstructured":"Veness MJ, Quinn DI, Ong CS et al (1999) Aggressive cutaneous malignancies following cardiothoracic transplantation: the Australian experience. Cancer 85:1758\u20131764","journal-title":"Cancer"},{"key":"1858_CR42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/00015550510042868","volume":"86","author":"Wulf","year":"2006","unstructured":"Wulf HC, Pavel S, Stender I et al (2006) Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients. Acta Derm Venereol 86:25\u201328","journal-title":"Acta Derm Venereol"},{"key":"1858_CR43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1046-2023(02)00209-8","volume":"28","author":"Yarosh","year":"2002","unstructured":"Yarosh DB, Boumakis S, Brown AB et al (2002) Measurement of UVB-Induced DNA damage and its consequences in models of immunosuppression. Methods 28:55\u201362","journal-title":"Methods"},{"key":"1858_CR44","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1523-1747.2000.00012.x","volume":"115","author":"Young","year":"2000","unstructured":"Young AR, Sheehan JM, Chadwick CA et al (2000) Protection by ultraviolet A and B sunscreens against in situ dipyrimidine photolesions in human epidermis is comparable to protection against sunburn. J Invest Dermatol 115:37\u201341","journal-title":"J Invest Dermatol"},{"key":"1858_CR45","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/0190-9622(92)70144-5","volume":"26","author":"Rowe","year":"1992","unstructured":"Rowe DE, Carroll RJ, Day CL Jr (1992) Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: implications for treatment modality selection. J Am Acad Dermatol 26:976\u2013990","journal-title":"J Am Acad Dermatol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-009-1858-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-009-1858-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-009-1858-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T08:05:39Z","timestamp":1685433939000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-009-1858-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,24]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["1858"],"URL":"https:\/\/doi.org\/10.1007\/s00105-009-1858-2","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,24]]}}}